» Articles » PMID: 6235362

Estimation of Renal Secretory Function for Organic Cations by Endogenous N1-methylnicotinamide in Rats with Experimental Renal Failure

Overview
Specialty Pharmacology
Date 1984 Feb 1
PMID 6235362
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

To assess whether the secretory clearance of N1-methylnicotinamide (NMN), an endogenous organic cation, represents renal tubular secretion of the organic cation, the relationship between the secretory clearance of NMN, CLscn(NMN), and that of tetraethylammonium bromide (TEA), CLscn(TEA), was examined in normal and experimental renal failure (ERF) rats. TEA was selected as a representative organic cation secreted by the kidney. ERF was induced by glycerol, folate, salicylate, uranium, and gentamicin, substances which have been demonstrated to produce specific damage to the kidney by pathophysiological studies. Glomerular filtration rate (GFR), CLscn(NMN), and CLscn(TEA) decreased significantly in most of ERF rats, while blood urea nitrogen (BUN) increased significantly in all ERF rats. There was a statistically significant correlation (r = 0.952, p less than 0.001) between the endogenous CLscn(NMN) and CLscn(TEA) in both the normal and ERF rats. Correlation analysis revealed that CLscn(NMN) was superior to GFR in the degree of relationship to CLscn(TEA), but BUN could not be used as an index for the secretion of NMN or TEA. Although the plasma concentration of NMN in most of the ERF rats was much higher than that in the normal rats, it affected neither the urinary clearance of NMN itself nor the excretion of TEA. From these findings, we propose that CLscn(NMN) can be used as an index to assess renal tubular function for the secretion of organic cations that are excreted by both filtration and secretion without reabsorption.

Citing Articles

Use of omics analysis for low-dose radiotoxicology and health risk assessment: the case of uranium.

Grison S, Souidi M Environ Epigenet. 2022; 8(1):dvac025.

PMID: 36518874 PMC: 9743459. DOI: 10.1093/eep/dvac025.


Early Metabolomic Markers of Acute Low-Dose Exposure to Uranium in Rats.

Grison S, Habchi B, Gloaguen C, Kereselidze D, Elie C, Martin J Metabolites. 2022; 12(5).

PMID: 35629925 PMC: 9147032. DOI: 10.3390/metabo12050421.


Serum metabolic profile of postoperative acute kidney injury following infant cardiac surgery with cardiopulmonary bypass.

Davidson J, Frank B, Urban T, Twite M, Jaggers J, Khailova L Pediatr Nephrol. 2021; 36(10):3259-3269.

PMID: 33954809 PMC: 8448922. DOI: 10.1007/s00467-021-05095-8.


Metabolomics reveals dose effects of low-dose chronic exposure to uranium in rats: identification of candidate biomarkers in urine samples.

Grison S, Fave G, Maillot M, Manens L, Delissen O, Blanchardon E Metabolomics. 2016; 12(10):154.

PMID: 27729830 PMC: 5025510. DOI: 10.1007/s11306-016-1092-8.


Metabolomics identifies a biological response to chronic low-dose natural uranium contamination in urine samples.

Grison S, Fave G, Maillot M, Manens L, Delissen O, Blanchardon E Metabolomics. 2013; 9(6):1168-1180.

PMID: 24273473 PMC: 3825637. DOI: 10.1007/s11306-013-0544-7.


References
1.
Preuss H, WEISS F, Janicki R, GOLDIN H . Studies on the mechanism of folate-induced growth in rat kidneys. J Pharmacol Exp Ther. 1972; 180(3):754-8. View

2.
Kassirer J . Clinical evaluation of kidney function--glomerular function. N Engl J Med. 1971; 285(7):385-9. DOI: 10.1056/NEJM197108122850706. View

3.
DETTLI L . Drug dosage in renal disease. Clin Pharmacokinet. 1976; 1(2):126-34. DOI: 10.2165/00003088-197601020-00004. View

4.
FAWCETT J, Scott J . A rapid and precise method for the determination of urea. J Clin Pathol. 1960; 13:156-9. PMC: 480024. DOI: 10.1136/jcp.13.2.156. View

5.
Holohan P, Ross C . Mechanisms of organic cation transport in kidney plasma membrane vesicles: 2. delta pH studies. J Pharmacol Exp Ther. 1981; 216(2):294-8. View